Effects of the 5-HT1A receptor agonist tandospirone on ACTH-induced sleep disturbance in rats

Ryuki Tsutsui, Kazuaki Shinomiya, Toshiaki Sendo, Yoshihisa Kitamura, Chiaki Kamei

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The aim of this study was to compare the effect of the serotonin (5-HT)1A receptor agonist tandospirone versus that of the benzodiazepine hypnotic flunitrazepam in a rat model of long-term adrenocorticotropic hormone (ACTH)-induced sleep disturbance. Rats implanted with electrodes for recording electroencephalogram and electromyogram were injected with ACTH once daily at a dose of 100 μg/rat. Administration of ACTH for 10 d caused a significant increase in sleep latency, decrease in non-rapid eye movement (non-REM) sleep time, and increase in wake time. Tandospirone caused a significant decrease in sleep latency and increase in non-REM sleep time in rats treated with ACTH. The effect of tandospirone on sleep patterns was antagonized by the 5-HT1A receptor antagonist WAY-100635. In contrast, flunitrazepam had no significant effect on sleep parameters in ACTH-treated rats. These results clearly indicate that long-term administration of ACTH causes sleep disturbance, and stimulating the 5-HT1A receptor by tandospirone may be efficacious for improving sleep in cases in which benzodiazepine hypnotics are ineffective.

Original languageEnglish
Pages (from-to)884-888
Number of pages5
JournalBiological and Pharmaceutical Bulletin
Volume38
Issue number6
Publication statusPublished - Jun 1 2015

Fingerprint

Serotonin 5-HT1 Receptor Agonists
Receptor, Serotonin, 5-HT1A
Adrenocorticotropic Hormone
Sleep
Flunitrazepam
Eye Movements
Hypnotics and Sedatives
Benzodiazepines
Serotonin 5-HT1 Receptor Antagonists
tandospirone
Implanted Electrodes
Electromyography
Electroencephalography
Serotonin

Keywords

  • Adrenocorticotropic hormone
  • Gamma-aminobutyric acid
  • Serotonin (5-HT)<inf>1A</inf> receptor
  • Sleep disturbance

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Cite this

Effects of the 5-HT1A receptor agonist tandospirone on ACTH-induced sleep disturbance in rats. / Tsutsui, Ryuki; Shinomiya, Kazuaki; Sendo, Toshiaki; Kitamura, Yoshihisa; Kamei, Chiaki.

In: Biological and Pharmaceutical Bulletin, Vol. 38, No. 6, 01.06.2015, p. 884-888.

Research output: Contribution to journalArticle

@article{d30af1280d3b473c820c65aa21e82d29,
title = "Effects of the 5-HT1A receptor agonist tandospirone on ACTH-induced sleep disturbance in rats",
abstract = "The aim of this study was to compare the effect of the serotonin (5-HT)1A receptor agonist tandospirone versus that of the benzodiazepine hypnotic flunitrazepam in a rat model of long-term adrenocorticotropic hormone (ACTH)-induced sleep disturbance. Rats implanted with electrodes for recording electroencephalogram and electromyogram were injected with ACTH once daily at a dose of 100 μg/rat. Administration of ACTH for 10 d caused a significant increase in sleep latency, decrease in non-rapid eye movement (non-REM) sleep time, and increase in wake time. Tandospirone caused a significant decrease in sleep latency and increase in non-REM sleep time in rats treated with ACTH. The effect of tandospirone on sleep patterns was antagonized by the 5-HT1A receptor antagonist WAY-100635. In contrast, flunitrazepam had no significant effect on sleep parameters in ACTH-treated rats. These results clearly indicate that long-term administration of ACTH causes sleep disturbance, and stimulating the 5-HT1A receptor by tandospirone may be efficacious for improving sleep in cases in which benzodiazepine hypnotics are ineffective.",
keywords = "Adrenocorticotropic hormone, Gamma-aminobutyric acid, Serotonin (5-HT)<inf>1A</inf> receptor, Sleep disturbance",
author = "Ryuki Tsutsui and Kazuaki Shinomiya and Toshiaki Sendo and Yoshihisa Kitamura and Chiaki Kamei",
year = "2015",
month = "6",
day = "1",
language = "English",
volume = "38",
pages = "884--888",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "6",

}

TY - JOUR

T1 - Effects of the 5-HT1A receptor agonist tandospirone on ACTH-induced sleep disturbance in rats

AU - Tsutsui, Ryuki

AU - Shinomiya, Kazuaki

AU - Sendo, Toshiaki

AU - Kitamura, Yoshihisa

AU - Kamei, Chiaki

PY - 2015/6/1

Y1 - 2015/6/1

N2 - The aim of this study was to compare the effect of the serotonin (5-HT)1A receptor agonist tandospirone versus that of the benzodiazepine hypnotic flunitrazepam in a rat model of long-term adrenocorticotropic hormone (ACTH)-induced sleep disturbance. Rats implanted with electrodes for recording electroencephalogram and electromyogram were injected with ACTH once daily at a dose of 100 μg/rat. Administration of ACTH for 10 d caused a significant increase in sleep latency, decrease in non-rapid eye movement (non-REM) sleep time, and increase in wake time. Tandospirone caused a significant decrease in sleep latency and increase in non-REM sleep time in rats treated with ACTH. The effect of tandospirone on sleep patterns was antagonized by the 5-HT1A receptor antagonist WAY-100635. In contrast, flunitrazepam had no significant effect on sleep parameters in ACTH-treated rats. These results clearly indicate that long-term administration of ACTH causes sleep disturbance, and stimulating the 5-HT1A receptor by tandospirone may be efficacious for improving sleep in cases in which benzodiazepine hypnotics are ineffective.

AB - The aim of this study was to compare the effect of the serotonin (5-HT)1A receptor agonist tandospirone versus that of the benzodiazepine hypnotic flunitrazepam in a rat model of long-term adrenocorticotropic hormone (ACTH)-induced sleep disturbance. Rats implanted with electrodes for recording electroencephalogram and electromyogram were injected with ACTH once daily at a dose of 100 μg/rat. Administration of ACTH for 10 d caused a significant increase in sleep latency, decrease in non-rapid eye movement (non-REM) sleep time, and increase in wake time. Tandospirone caused a significant decrease in sleep latency and increase in non-REM sleep time in rats treated with ACTH. The effect of tandospirone on sleep patterns was antagonized by the 5-HT1A receptor antagonist WAY-100635. In contrast, flunitrazepam had no significant effect on sleep parameters in ACTH-treated rats. These results clearly indicate that long-term administration of ACTH causes sleep disturbance, and stimulating the 5-HT1A receptor by tandospirone may be efficacious for improving sleep in cases in which benzodiazepine hypnotics are ineffective.

KW - Adrenocorticotropic hormone

KW - Gamma-aminobutyric acid

KW - Serotonin (5-HT)<inf>1A</inf> receptor

KW - Sleep disturbance

UR - http://www.scopus.com/inward/record.url?scp=84936764646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936764646&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 884

EP - 888

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 6

ER -